Skip to main content

Table 2 Correlations between EQ-5D-3L and Other Outcome Measures Using Multiple Imputation

From: Convergent validity of the EQ-5D-3L in a randomized-controlled trial of the Housing First model

Stratum and Time

QOLI-20

CSI

RAS

Comorbidities

All

 0

0.52 (0.47 to 0.58)

−0.57a (− 0.63 to − 0.51)

0.42a (0.36 to 0.47)

− 0.51a (− 0.57 to − 0.44)

 6

0.43 (0.37 to 0.48)

− 0.53a (− 0.58 to − 0.48)

 12

0.47 (0.41 to 0.53)

− 0.54a (− 0.59 to − 0.48)

 18

0.40 (0.33 to 0.45)

− 0.47a (− 0.54 to − 0.42)

 24

0.37 (0.31 to 0.43)

− 0.47a (− 0.52 to − 0.41)

0.31a (0.24 to 0.38)

High Needs Mental Illness

 0

0.49 (0.38 to 0.58)

− 0.63a (− 0.71 to − 0.52)

0.43a (0.34 to 0.52)

− 0.59a (− 0.68 to − 0.49)

 6

0.40 (0.32 to 0.49)

− 0.51a (− 0.60 to − 0.43)

 12

0.46 (0.39 to 0.52)

− 0.52a (− 0.58 to − 0.43)

 18

0.42 (0.31 to 0.52)

− 0.51a (− 0.59 to − 0.42)

 24

0.39 (0.28 to 0.48)

− 0.50a (− 0.58 to − 0.40)

0.34a (0.22 to 0.44)

Moderate Needs Mental Illness

 0

0.54 (0.46 to 0.59)

− 0.53a (− 0.58 to − 0.45)

0.40a (0.33 to 0.49)

−0.44a (− 0.54 to − 0.36)

 6

0.44 (0.38 to 0.52)

−0.55a (− 0.62 to − 0.48)

 12

0.48 (0.40 to 0.55)

−0.55a (− 0.62 to − 0.48)

 18

0.38 (0.30 to 0.46)

−0.45a (− 0.53 to − 0.37)

 24

0.35 (0.27 to 0.43)

−0.45a (− 0.51 to − 0.37)

0.30 (0.21 to 0.37)

High Thought Impairment

 0

0.52 (0.42 to 0.61)

−0.62a (− 0.71 to − 0.53)

0.40a (0.30 to 0.49)

−0.56a (− 0.65 to − 0.47)

 6

0.35 (0.21 to 0.45)

−0.55a (− 0.64 to − 0.44)

 12

0.44 (0.32 to 0.54)

−0.59a (− 0.67 to − 0.49)

 18

0.41 (0.22 to 0.53)

−0.48a (− 0.62 to − 0.27)

 24

0.41 (0.27 to 0.55)

−0.45a (− 0.59 to − 0.24)

0.24 (− 0.02 to 0.41)

Low Thought Impairment

 0

0.52 (0.44 to 0.58)

− 0.52a (− 0.59 to − 0.45)

0.43a (0.35 to 0.51)

−0.45a (− 0.55 to − 0.35)

 6

0.47 (0.37 to 0.54)

−0.54a (− 0.62 to − 0.47)

 12

0.49 (0.40 to 0.57)

−0.52a (− 0.60 to − 0.42)

 18

0.38 (0.28 to 0.48)

−0.46a (− 0.54 to − 0.37)

 24

0.33 (0.23 to 0.43)

−0.45a (− 0.52 to − 0.37)

0.33a (0.24 to 0.42)

High Interview Confidence Only

 0

0.54 (0.45 to 0.61)

−0.48a (− 0.57 to − 0.33)

0.39a (0.28 to 0.51)

−0.45a (− 0.56 to − 0.33)

 6

0.49 (0.39 to 0.57)

−0.53a (− 0.61 to − 0.41)

 12

0.51 (0.38 to 0.61)

−0.46a (− 0.58 to − 0.36)

 18

0.38 (0.25 to 0.49)

−0.48a (− 0.58 to − 0.35)

 24

0.42 (0.30 to 0.52)

−0.53a (− 0.62 to − 0.41)

0.37a (0.24 to 0.46)

High or Moderate Interviewer Confidence Only

 0

0.52 (0.46 to 0.57)

−0.56a (− 0.62 to − 0.51)

0.42a (0.35 to 0.48)

−0.49a (− 0.56 to − 0.42)

 6

0.40 (0.34 to 0.47)

−0.52a (− 0.57 to − 0.45)

 12

0.47 (0.40 to 0.55)

−0.52a (− 0.59 to − 0.45)

 18

0.38 (0.31 to 0.46)

−0.45a (− 0.52 to − 0.37)

 24

0.35 (0.27 to 0.44)

−0.45a (− 0.52 to − 0.38)

0.34a (0.28 to 0.42)

  1. QOLI-20 Lehman Quality of Life Interview 20 index total, CSI Colorado Symptom Index, RAS Recovery Assessment Scale
  2. a Met pre-defined threshold for correlation (r > |0.6| for QOLI-20, r > |0.3| for CSI, RAS, and number of comorbidities)